Cargando…
Effect of antiplatelet therapy on the incidence, prognosis, and rebleeding of intracerebral hemorrhage
OBJECTIVE: Antiplatelet medications are increasingly being used for primary and secondary prevention of ischemic attacks owing to the increasing prevalence of ischemic stroke occurrences. Currently, many patients receive antiplatelet therapy (APT) to prevent thromboembolic events. However, long‐term...
Autores principales: | Li, Yunjie, Liu, Xia, Chen, Shiling, Wang, Jingyi, Pan, Chao, Li, Gaigai, Tang, Zhouping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10173719/ https://www.ncbi.nlm.nih.gov/pubmed/36942509 http://dx.doi.org/10.1111/cns.14175 |
Ejemplares similares
-
Effects of Prior Antiplatelet Therapy on the Prognosis of Primary Intracerebral Hemorrhage: A Meta-analysis
por: Yu, Hai-Han, et al.
Publicado: (2017) -
Application of Small Molecules in the Central Nervous System Direct Neuronal Reprogramming
por: Wang, Jingyi, et al.
Publicado: (2022) -
Surgical Robotics for Intracerebral Hemorrhage Treatment: State of the Art and Future Directions
por: Wu, Zhuojin, et al.
Publicado: (2023) -
Overexpression of CX3CR1 in Adipose-Derived Stem Cells Promotes Cell Migration and Functional Recovery After Experimental Intracerebral Hemorrhage
por: Li, Gaigai, et al.
Publicado: (2019) -
The impact of antiplatelet drugs on recurrent stroke in patients with intracerebral hemorrhage
por: Wong, Yi-Sin, et al.
Publicado: (2023)